Zhu, X. et al. 2009. Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis. Acta Oncologica. 48, 1 (Jan. 2009), 9–17. DOI:https://doi.org/10.1080/02841860802314720.